Home > News > BioSante Pharmaceuticals Announces 2003 Key Achievements
March 9th, 2004
BioSante Pharmaceuticals Announces 2003 Key Achievements
BioSante Pharmaceuticals (Amex:BPA) today announced key achievements and financial results for the year ended December 31, 2003. "We are quite pleased with our achievements and progress in the last year. Recent FDA actions and hormone therapy market indications are very encouraging," said Stephen M. Simes, president and chief executive officer of BioSante. "The most exciting recent event affecting the estrogen market is the FDA's approval of an estrogen gel developed by Solvay Pharmaceuticals, Inc.
Aspen Aerogels, Inc. Schedules Fourth Quarter and Fiscal 2014 Earnings Release and Conference Call for February 26, 2015 February 11th, 2015
Arrowhead to Report Fiscal 2015 First Quarter Financial Results February 2nd, 2015
Graphenea sales more than double in 2014 January 29th, 2015
Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 2, 2015 January 7th, 2015